Αποτελέσματα Αναζήτησης
26 Αυγ 2022 · ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Ventricular Arrhythmias and the Prevention of Sudden Cardiac (SCD).
- Clinical Practice Guidelines
ESC Clinical Practice Guidelines aim to present all the...
- Clinical Practice Guidelines
26 Αυγ 2022 · In case of a known idiopathic VT (Figure 4), treatment with beta-blockers (for RVOT VT) 306 or verapamil (for fascicular VT) 307 is recommended for acute conversion. Although verapamil may terminate other types of idiopathic VT, 307 important adverse effects such as severe hypotension may occur.
13 Οκτ 2023 · Heart arrhythmia treatment is usually only needed if the irregular heartbeat causes significant symptoms or puts you at risk of more-serious heart problems. Treatment for heart arrhythmias may include medicines, special actions called vagal maneuvers, procedures or surgery.
ESC Clinical Practice Guidelines aim to present all the relevant evidence on a particular clinical issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical medical decision-making.
21 Οκτ 2022 · 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43 (40):3997-4126. doi: 10.1093/eurheartj/ehac262. Authors.
The recommendation for ICD implantation in CPVT patients with arrhythmogenic syncope is stronger in the AHA/ACC/HRS than the ESC guidelines (Class I vs Class IIa). The ESC guideline requires ongoing flecainide therapy in addition to treatment with the highest tolerated dose of beta-blocker.
24 Δεκ 2022 · The review presents new indications to help with diagnosis and treatment of ventricular arrhythmia (VA) in patients with various etiologies of rhythm disturbances, including patients with...
